<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04878679</url>
  </required_header>
  <id_info>
    <org_study_id>ForoItalico1</org_study_id>
    <nct_id>NCT04878679</nct_id>
  </id_info>
  <brief_title>Effect of WB-EMS on Parkinson's Disease</brief_title>
  <official_title>Effects of Combined Whole Body Electromiostimulation (WB-EMS) and Dynamic Movements on Motor and Cognitive Performance, Neurotrophic Factors and Alpha-synuclein in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli studi di Roma Foro Italico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Giuseppe Calcagno</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Giovanni Fiorilli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Andrea Buonsenso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marco Centorbi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università degli studi di Roma Foro Italico</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to establish adequate and suitable protocols for PD patients and to determine the&#xD;
      WB-EMS effects on muscle strength, balance, walking, cognitive functions,neurotrophic factors&#xD;
      and alpha-synuclein. Thirty-six PD patients, aged from 50 to 80 years, will be recruited and&#xD;
      randomly assigned to two experimental groups (EGs and EGc) and one control group (CG), in&#xD;
      order to perform dynamic movements with WB-EMS. EGs will undergo to 12-20 minutes of&#xD;
      progressive supervised WB-EMS (4 sec. 85 HZ and 4 sec. rests) combined to light dynamic&#xD;
      movements, two-time per week for 12/24 weeks. EGe will undergo to 12-20 minutes of&#xD;
      progressive supervised WB-EMS 7 Hz) combined with cardiovascular training with rowing&#xD;
      machine. CG will not perform any type of physical activity. Pre and post intervention&#xD;
      assessment will be carried out on the following areas: physical assessment, neurocognitive,&#xD;
      neurotrophic factors and alpha-synuclein assesments. A 3 months follow-up will be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>REPETITIONS NUMBER CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>30S ARM CURL TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>REPETITIONS NUMBER CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>30S SIT TO STAND TEST;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TIME(S) CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>SODA POP TEST ;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TIME(S) CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>8 FEET UP AND GO TEST ;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DISTANCE (M) CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>6 MINUTE WALKING TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>UPPER LIMB STRENGHT CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>HAND GRIP TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LOWER BODY FLEXIBILITY</measure>
    <time_frame>14 Weeks</time_frame>
    <description>CHAIR SIT AND REACH TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BALANCE AND STABILITY TEST CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>TINETTI BALANCE AND GAIT EVALUATION TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NUMBER OF ERRORS CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>STROOP TEST;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NUMBER OF ERRORS CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>REY AUDITORY VERBAL LEARNING TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TIME(S) CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>STROOP TEST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TIME(S) CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>TRAIL MAKING TEST CHANGE</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NEUROTROPHIC FACTORS CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>BLOOD DRAW</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ALPHA-SYNUCLEIN CHANGE</measure>
    <time_frame>14 Weeks</time_frame>
    <description>BLOOD DRAW</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>&quot;Strength training + WB-EMS&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Strength training combined with WB-EMS : 2 times/week for 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiovascular training + WB-EMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cardiovascular training, using rowing machine, combined with WB-EMS : 2 times/week for 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No physical activity</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Strenght training combined with WB-EMS</intervention_name>
    <description>Bodyweight exercise training combined with WB-EMS (2 times/week) with a 85Hz electrical impulse</description>
    <arm_group_label>&quot;Strength training + WB-EMS&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiovascular training with WB-EMS</intervention_name>
    <description>Cardiovascular training , using the rowing machine, combined with WB-EMS (2 times/week) with a 7Hz electrical impulse</description>
    <arm_group_label>Cardiovascular training + WB-EMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>No physical activity</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age from 50 to 80 years old&#xD;
&#xD;
          -  clinical diagnosis of parkinson's disease from 1 to 3 of Hoehn and Yahr Scale&#xD;
&#xD;
          -  no partecipation to other physical activity program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MMSE values &lt; 24&#xD;
&#xD;
          -  inability to walk 6 minutes without assistance&#xD;
&#xD;
          -  use of medications and other things that may affect cognitive and motor functions&#xD;
&#xD;
          -  presence of contraindications in the use of WB-EMS&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandra di Cagno</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli studi di Roma Foro Italico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Università degli Studi del Molise</name>
      <address>
        <city>Campobasso</city>
        <zip>86100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 21, 2021</study_first_submitted>
  <study_first_submitted_qc>May 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli studi di Roma Foro Italico</investigator_affiliation>
    <investigator_full_name>Alessandra di Cagno</investigator_full_name>
    <investigator_title>Prof. Alessandra di Cagno</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

